Trial Profile
Phase III Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer After Prior Anthracycline-based Adjuvant Chemotherapy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 Dec 2021
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary) ; Gemcitabine; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms VICTORIA
- Sponsors Pierre Fabre
- 18 Dec 2021 This trial has been completed in Italy and Czech Republic.
- 09 Aug 2019 Status changed to discontinued.